nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—SLCO1A2—Chlorambucil—testicular cancer	0.167	0.225	CbGbCtD
Hydrocortisone—ABCG2—Dactinomycin—testicular cancer	0.0603	0.081	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0526	0.0706	CbGbCtD
Hydrocortisone—CYP3A7—Ifosfamide—testicular cancer	0.0526	0.0706	CbGbCtD
Hydrocortisone—ABCG2—Carboplatin—testicular cancer	0.0405	0.0544	CbGbCtD
Hydrocortisone—CYP3A5—Ifosfamide—testicular cancer	0.0394	0.053	CbGbCtD
Hydrocortisone—CYP2C8—Ifosfamide—testicular cancer	0.0379	0.0509	CbGbCtD
Hydrocortisone—ABCG2—Cisplatin—testicular cancer	0.0346	0.0465	CbGbCtD
Hydrocortisone—ABCG2—Etoposide—testicular cancer	0.034	0.0457	CbGbCtD
Hydrocortisone—SLCO1A2—Methotrexate—testicular cancer	0.03	0.0403	CbGbCtD
Hydrocortisone—ABCG2—Doxorubicin—testicular cancer	0.0232	0.0312	CbGbCtD
Hydrocortisone—ABCG2—Methotrexate—testicular cancer	0.0225	0.0302	CbGbCtD
Hydrocortisone—ABCB1—Dactinomycin—testicular cancer	0.0217	0.0292	CbGbCtD
Hydrocortisone—CYP3A5—Etoposide—testicular cancer	0.0188	0.0253	CbGbCtD
Hydrocortisone—SHBG—seminiferous tubule of testis—testicular cancer	0.0183	0.303	CbGeAlD
Hydrocortisone—CYP2C8—Etoposide—testicular cancer	0.0181	0.0243	CbGbCtD
Hydrocortisone—CYP3A4—Ifosfamide—testicular cancer	0.0154	0.0207	CbGbCtD
Hydrocortisone—ABCB1—Vinblastine—testicular cancer	0.0136	0.0183	CbGbCtD
Hydrocortisone—ABCB1—Cisplatin—testicular cancer	0.0125	0.0168	CbGbCtD
Hydrocortisone—ABCB1—Etoposide—testicular cancer	0.0123	0.0165	CbGbCtD
Hydrocortisone—SHBG—semen—testicular cancer	0.0101	0.168	CbGeAlD
Hydrocortisone—ABCB1—Doxorubicin—testicular cancer	0.00837	0.0112	CbGbCtD
Hydrocortisone—CYP3A4—Vinblastine—testicular cancer	0.00816	0.011	CbGbCtD
Hydrocortisone—ABCB1—Methotrexate—testicular cancer	0.0081	0.0109	CbGbCtD
Hydrocortisone—CYP3A4—Etoposide—testicular cancer	0.00735	0.00987	CbGbCtD
Hydrocortisone—CYP3A4—Doxorubicin—testicular cancer	0.00501	0.00673	CbGbCtD
Hydrocortisone—ANXA1—embryo—testicular cancer	0.00341	0.0566	CbGeAlD
Hydrocortisone—ANXA1—seminal vesicle—testicular cancer	0.0032	0.0532	CbGeAlD
Hydrocortisone—ANXA1—gonad—testicular cancer	0.00231	0.0384	CbGeAlD
Hydrocortisone—ANXA1—female gonad—testicular cancer	0.00188	0.0312	CbGeAlD
Hydrocortisone—CYP11B2—lymph node—testicular cancer	0.00177	0.0294	CbGeAlD
Hydrocortisone—ANXA1—testis—testicular cancer	0.00167	0.0277	CbGeAlD
Hydrocortisone—SHBG—gonad—testicular cancer	0.00155	0.0257	CbGeAlD
Hydrocortisone—SHBG—female gonad—testicular cancer	0.00126	0.0209	CbGeAlD
Hydrocortisone—ANXA1—lymph node—testicular cancer	0.00121	0.0201	CbGeAlD
Hydrocortisone—ABCG2—seminal vesicle—testicular cancer	0.00121	0.02	CbGeAlD
Hydrocortisone—NR3C1—embryo—testicular cancer	0.00118	0.0197	CbGeAlD
Hydrocortisone—SHBG—testis—testicular cancer	0.00111	0.0185	CbGeAlD
Hydrocortisone—NR3C1—seminal vesicle—testicular cancer	0.00111	0.0185	CbGeAlD
Hydrocortisone—SLCO1A2—testis—testicular cancer	0.000926	0.0154	CbGeAlD
Hydrocortisone—NR3C1—gonad—testicular cancer	0.000804	0.0133	CbGeAlD
Hydrocortisone—ABCG2—female gonad—testicular cancer	0.000709	0.0118	CbGeAlD
Hydrocortisone—CYP3A5—female gonad—testicular cancer	0.000658	0.0109	CbGeAlD
Hydrocortisone—NR3C1—female gonad—testicular cancer	0.000653	0.0108	CbGeAlD
Hydrocortisone—CYP2C8—testis—testicular cancer	0.000647	0.0107	CbGeAlD
Hydrocortisone—ABCB1—embryo—testicular cancer	0.000634	0.0105	CbGeAlD
Hydrocortisone—ABCG2—testis—testicular cancer	0.000629	0.0104	CbGeAlD
Hydrocortisone—ABCB1—seminal vesicle—testicular cancer	0.000596	0.00988	CbGeAlD
Hydrocortisone—NR3C1—testis—testicular cancer	0.000579	0.00962	CbGeAlD
Hydrocortisone—ABCG2—lymph node—testicular cancer	0.000456	0.00757	CbGeAlD
Hydrocortisone—ABCB1—gonad—testicular cancer	0.00043	0.00714	CbGeAlD
Hydrocortisone—NR3C1—lymph node—testicular cancer	0.00042	0.00697	CbGeAlD
Hydrocortisone—ABCB1—female gonad—testicular cancer	0.00035	0.0058	CbGeAlD
Hydrocortisone—ABCB1—testis—testicular cancer	0.00031	0.00515	CbGeAlD
Hydrocortisone—ABCB1—lymph node—testicular cancer	0.000225	0.00373	CbGeAlD
Hydrocortisone—Affect lability—Doxorubicin—testicular cancer	0.000181	0.000925	CcSEcCtD
Hydrocortisone—Hypokalaemia—Epirubicin—testicular cancer	0.000181	0.000925	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00018	0.000923	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00018	0.000922	CcSEcCtD
Hydrocortisone—Pancreatitis—Methotrexate—testicular cancer	0.00018	0.00092	CcSEcCtD
Hydrocortisone—Discomfort—Etoposide—testicular cancer	0.000179	0.000918	CcSEcCtD
Hydrocortisone—Hypotension—Cisplatin—testicular cancer	0.000177	0.000909	CcSEcCtD
Hydrocortisone—Hypersensitivity—Dactinomycin—testicular cancer	0.000177	0.000907	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.000175	0.000896	CcSEcCtD
Hydrocortisone—Muscular weakness—Epirubicin—testicular cancer	0.000175	0.000896	CcSEcCtD
Hydrocortisone—Urticaria—Ifosfamide—testicular cancer	0.000175	0.000896	CcSEcCtD
Hydrocortisone—Cardiac arrest—Doxorubicin—testicular cancer	0.000175	0.000894	CcSEcCtD
Hydrocortisone—Body temperature increased—Ifosfamide—testicular cancer	0.000174	0.000892	CcSEcCtD
Hydrocortisone—Abdominal pain—Ifosfamide—testicular cancer	0.000174	0.000892	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Etoposide—testicular cancer	0.000174	0.000891	CcSEcCtD
Hydrocortisone—Mood swings—Doxorubicin—testicular cancer	0.000174	0.000891	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000173	0.000886	CcSEcCtD
Hydrocortisone—Infection—Etoposide—testicular cancer	0.000173	0.000885	CcSEcCtD
Hydrocortisone—Abdominal distension—Epirubicin—testicular cancer	0.000173	0.000884	CcSEcCtD
Hydrocortisone—Asthenia—Dactinomycin—testicular cancer	0.000172	0.000883	CcSEcCtD
Hydrocortisone—Paraesthesia—Cisplatin—testicular cancer	0.00017	0.000873	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Methotrexate—testicular cancer	0.00017	0.000872	CcSEcCtD
Hydrocortisone—Tachycardia—Etoposide—testicular cancer	0.00017	0.000869	CcSEcCtD
Hydrocortisone—Skin disorder—Etoposide—testicular cancer	0.000169	0.000865	CcSEcCtD
Hydrocortisone—Dry skin—Doxorubicin—testicular cancer	0.000168	0.000862	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Etoposide—testicular cancer	0.000168	0.000861	CcSEcCtD
Hydrocortisone—Pancreatitis—Epirubicin—testicular cancer	0.000168	0.000861	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Doxorubicin—testicular cancer	0.000168	0.000859	CcSEcCtD
Hydrocortisone—Hypokalaemia—Doxorubicin—testicular cancer	0.000167	0.000856	CcSEcCtD
Hydrocortisone—Anorexia—Etoposide—testicular cancer	0.000166	0.000849	CcSEcCtD
Hydrocortisone—Decreased appetite—Cisplatin—testicular cancer	0.000165	0.000845	CcSEcCtD
Hydrocortisone—Diarrhoea—Dactinomycin—testicular cancer	0.000164	0.000842	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000164	0.000839	CcSEcCtD
Hydrocortisone—Vomiting—Bleomycin—testicular cancer	0.000164	0.000839	CcSEcCtD
Hydrocortisone—Infestation NOS—Methotrexate—testicular cancer	0.000163	0.000837	CcSEcCtD
Hydrocortisone—Infestation—Methotrexate—testicular cancer	0.000163	0.000837	CcSEcCtD
Hydrocortisone—Hypotension—Etoposide—testicular cancer	0.000163	0.000832	CcSEcCtD
Hydrocortisone—Rash—Bleomycin—testicular cancer	0.000162	0.000832	CcSEcCtD
Hydrocortisone—Pain—Cisplatin—testicular cancer	0.000162	0.000832	CcSEcCtD
Hydrocortisone—Dermatitis—Bleomycin—testicular cancer	0.000162	0.000831	CcSEcCtD
Hydrocortisone—Hypersensitivity—Ifosfamide—testicular cancer	0.000162	0.000831	CcSEcCtD
Hydrocortisone—Muscular weakness—Doxorubicin—testicular cancer	0.000162	0.000829	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000162	0.000829	CcSEcCtD
Hydrocortisone—Abdominal distension—Doxorubicin—testicular cancer	0.00016	0.000818	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000159	0.000816	CcSEcCtD
Hydrocortisone—Asthenia—Ifosfamide—testicular cancer	0.000158	0.000809	CcSEcCtD
Hydrocortisone—Feeling abnormal—Cisplatin—testicular cancer	0.000156	0.000801	CcSEcCtD
Hydrocortisone—Paraesthesia—Etoposide—testicular cancer	0.000156	0.0008	CcSEcCtD
Hydrocortisone—Weight increased—Epirubicin—testicular cancer	0.000156	0.000799	CcSEcCtD
Hydrocortisone—Pruritus—Ifosfamide—testicular cancer	0.000156	0.000798	CcSEcCtD
Hydrocortisone—Pancreatitis—Doxorubicin—testicular cancer	0.000156	0.000797	CcSEcCtD
Hydrocortisone—Weight decreased—Epirubicin—testicular cancer	0.000155	0.000794	CcSEcCtD
Hydrocortisone—Nausea—Bleomycin—testicular cancer	0.000153	0.000784	CcSEcCtD
Hydrocortisone—Infestation NOS—Epirubicin—testicular cancer	0.000153	0.000783	CcSEcCtD
Hydrocortisone—Infestation—Epirubicin—testicular cancer	0.000153	0.000783	CcSEcCtD
Hydrocortisone—Vomiting—Dactinomycin—testicular cancer	0.000153	0.000783	CcSEcCtD
Hydrocortisone—Rash—Dactinomycin—testicular cancer	0.000152	0.000776	CcSEcCtD
Hydrocortisone—Decreased appetite—Etoposide—testicular cancer	0.000151	0.000774	CcSEcCtD
Hydrocortisone—Diarrhoea—Ifosfamide—testicular cancer	0.000151	0.000772	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Etoposide—testicular cancer	0.00015	0.000769	CcSEcCtD
Hydrocortisone—Body temperature increased—Cisplatin—testicular cancer	0.00015	0.000769	CcSEcCtD
Hydrocortisone—Fatigue—Etoposide—testicular cancer	0.00015	0.000768	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Epirubicin—testicular cancer	0.00015	0.000767	CcSEcCtD
Hydrocortisone—Pain—Etoposide—testicular cancer	0.000149	0.000762	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000147	0.000755	CcSEcCtD
Hydrocortisone—Haemoglobin—Methotrexate—testicular cancer	0.000147	0.000755	CcSEcCtD
Hydrocortisone—Haemorrhage—Methotrexate—testicular cancer	0.000147	0.000751	CcSEcCtD
Hydrocortisone—Dizziness—Ifosfamide—testicular cancer	0.000146	0.000746	CcSEcCtD
Hydrocortisone—Weight increased—Doxorubicin—testicular cancer	0.000144	0.000739	CcSEcCtD
Hydrocortisone—Weight decreased—Doxorubicin—testicular cancer	0.000144	0.000735	CcSEcCtD
Hydrocortisone—Feeling abnormal—Etoposide—testicular cancer	0.000143	0.000734	CcSEcCtD
Hydrocortisone—Nausea—Dactinomycin—testicular cancer	0.000143	0.000731	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Etoposide—testicular cancer	0.000142	0.000728	CcSEcCtD
Hydrocortisone—Infestation NOS—Doxorubicin—testicular cancer	0.000141	0.000724	CcSEcCtD
Hydrocortisone—Infestation—Doxorubicin—testicular cancer	0.000141	0.000724	CcSEcCtD
Hydrocortisone—Vomiting—Ifosfamide—testicular cancer	0.00014	0.000717	CcSEcCtD
Hydrocortisone—Hypersensitivity—Cisplatin—testicular cancer	0.00014	0.000716	CcSEcCtD
Hydrocortisone—Bradycardia—Epirubicin—testicular cancer	0.00014	0.000716	CcSEcCtD
Hydrocortisone—Rash—Ifosfamide—testicular cancer	0.000139	0.000711	CcSEcCtD
Hydrocortisone—Dermatitis—Ifosfamide—testicular cancer	0.000139	0.000711	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000139	0.00071	CcSEcCtD
Hydrocortisone—Urticaria—Etoposide—testicular cancer	0.000138	0.000708	CcSEcCtD
Hydrocortisone—Haemoglobin—Epirubicin—testicular cancer	0.000138	0.000706	CcSEcCtD
Hydrocortisone—Abdominal pain—Etoposide—testicular cancer	0.000137	0.000704	CcSEcCtD
Hydrocortisone—Body temperature increased—Etoposide—testicular cancer	0.000137	0.000704	CcSEcCtD
Hydrocortisone—Haemorrhage—Epirubicin—testicular cancer	0.000137	0.000703	CcSEcCtD
Hydrocortisone—Eye disorder—Methotrexate—testicular cancer	0.000137	0.000702	CcSEcCtD
Hydrocortisone—Asthenia—Cisplatin—testicular cancer	0.000136	0.000698	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Epirubicin—testicular cancer	0.000135	0.000691	CcSEcCtD
Hydrocortisone—Immune system disorder—Methotrexate—testicular cancer	0.000132	0.000678	CcSEcCtD
Hydrocortisone—Nausea—Ifosfamide—testicular cancer	0.000131	0.00067	CcSEcCtD
Hydrocortisone—Diarrhoea—Cisplatin—testicular cancer	0.00013	0.000665	CcSEcCtD
Hydrocortisone—Bradycardia—Doxorubicin—testicular cancer	0.000129	0.000662	CcSEcCtD
Hydrocortisone—Mental disorder—Methotrexate—testicular cancer	0.000128	0.000658	CcSEcCtD
Hydrocortisone—Eye disorder—Epirubicin—testicular cancer	0.000128	0.000657	CcSEcCtD
Hydrocortisone—Hypersensitivity—Etoposide—testicular cancer	0.000128	0.000656	CcSEcCtD
Hydrocortisone—Malnutrition—Methotrexate—testicular cancer	0.000128	0.000654	CcSEcCtD
Hydrocortisone—Erythema—Methotrexate—testicular cancer	0.000128	0.000654	CcSEcCtD
Hydrocortisone—Haemoglobin—Doxorubicin—testicular cancer	0.000128	0.000654	CcSEcCtD
Hydrocortisone—Haemorrhage—Doxorubicin—testicular cancer	0.000127	0.00065	CcSEcCtD
Hydrocortisone—Asthenia—Etoposide—testicular cancer	0.000125	0.000639	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Doxorubicin—testicular cancer	0.000125	0.000639	CcSEcCtD
Hydrocortisone—Immune system disorder—Epirubicin—testicular cancer	0.000124	0.000635	CcSEcCtD
Hydrocortisone—Pruritus—Etoposide—testicular cancer	0.000123	0.00063	CcSEcCtD
Hydrocortisone—Arrhythmia—Epirubicin—testicular cancer	0.000123	0.000628	CcSEcCtD
Hydrocortisone—Vomiting—Cisplatin—testicular cancer	0.000121	0.000618	CcSEcCtD
Hydrocortisone—Mental disorder—Epirubicin—testicular cancer	0.00012	0.000616	CcSEcCtD
Hydrocortisone—Rash—Cisplatin—testicular cancer	0.00012	0.000613	CcSEcCtD
Hydrocortisone—Dermatitis—Cisplatin—testicular cancer	0.00012	0.000613	CcSEcCtD
Hydrocortisone—Erythema—Epirubicin—testicular cancer	0.000119	0.000612	CcSEcCtD
Hydrocortisone—Malnutrition—Epirubicin—testicular cancer	0.000119	0.000612	CcSEcCtD
Hydrocortisone—Diarrhoea—Etoposide—testicular cancer	0.000119	0.00061	CcSEcCtD
Hydrocortisone—Eye disorder—Doxorubicin—testicular cancer	0.000119	0.000608	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Methotrexate—testicular cancer	0.000118	0.000607	CcSEcCtD
Hydrocortisone—Malaise—Methotrexate—testicular cancer	0.000115	0.00059	CcSEcCtD
Hydrocortisone—Dizziness—Etoposide—testicular cancer	0.000115	0.000589	CcSEcCtD
Hydrocortisone—Immune system disorder—Doxorubicin—testicular cancer	0.000115	0.000587	CcSEcCtD
Hydrocortisone—Vertigo—Methotrexate—testicular cancer	0.000115	0.000587	CcSEcCtD
Hydrocortisone—Arrhythmia—Doxorubicin—testicular cancer	0.000113	0.000581	CcSEcCtD
Hydrocortisone—Nausea—Cisplatin—testicular cancer	0.000113	0.000578	CcSEcCtD
Hydrocortisone—Mental disorder—Doxorubicin—testicular cancer	0.000111	0.00057	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Epirubicin—testicular cancer	0.000111	0.000568	CcSEcCtD
Hydrocortisone—Convulsion—Methotrexate—testicular cancer	0.000111	0.000566	CcSEcCtD
Hydrocortisone—Vomiting—Etoposide—testicular cancer	0.000111	0.000566	CcSEcCtD
Hydrocortisone—Malnutrition—Doxorubicin—testicular cancer	0.000111	0.000566	CcSEcCtD
Hydrocortisone—Erythema—Doxorubicin—testicular cancer	0.000111	0.000566	CcSEcCtD
Hydrocortisone—Rash—Etoposide—testicular cancer	0.00011	0.000562	CcSEcCtD
Hydrocortisone—Dermatitis—Etoposide—testicular cancer	0.00011	0.000561	CcSEcCtD
Hydrocortisone—Headache—Etoposide—testicular cancer	0.000109	0.000558	CcSEcCtD
Hydrocortisone—Myalgia—Methotrexate—testicular cancer	0.000109	0.000557	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000108	0.000553	CcSEcCtD
Hydrocortisone—Malaise—Epirubicin—testicular cancer	0.000108	0.000552	CcSEcCtD
Hydrocortisone—Discomfort—Methotrexate—testicular cancer	0.000107	0.00055	CcSEcCtD
Hydrocortisone—Vertigo—Epirubicin—testicular cancer	0.000107	0.00055	CcSEcCtD
Hydrocortisone—Syncope—Epirubicin—testicular cancer	0.000107	0.000549	CcSEcCtD
Hydrocortisone—Loss of consciousness—Epirubicin—testicular cancer	0.000105	0.000538	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Methotrexate—testicular cancer	0.000104	0.000534	CcSEcCtD
Hydrocortisone—Convulsion—Epirubicin—testicular cancer	0.000104	0.00053	CcSEcCtD
Hydrocortisone—Infection—Methotrexate—testicular cancer	0.000104	0.00053	CcSEcCtD
Hydrocortisone—Nausea—Etoposide—testicular cancer	0.000103	0.000529	CcSEcCtD
Hydrocortisone—Hypertension—Epirubicin—testicular cancer	0.000103	0.000528	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000103	0.000525	CcSEcCtD
Hydrocortisone—Nervous system disorder—Methotrexate—testicular cancer	0.000102	0.000523	CcSEcCtD
Hydrocortisone—Myalgia—Epirubicin—testicular cancer	0.000102	0.000521	CcSEcCtD
Hydrocortisone—Anxiety—Epirubicin—testicular cancer	0.000101	0.000519	CcSEcCtD
Hydrocortisone—Skin disorder—Methotrexate—testicular cancer	0.000101	0.000518	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000101	0.000517	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Methotrexate—testicular cancer	0.000101	0.000516	CcSEcCtD
Hydrocortisone—Discomfort—Epirubicin—testicular cancer	0.0001	0.000515	CcSEcCtD
Hydrocortisone—Malaise—Doxorubicin—testicular cancer	9.97e-05	0.000511	CcSEcCtD
Hydrocortisone—Vertigo—Doxorubicin—testicular cancer	9.93e-05	0.000509	CcSEcCtD
Hydrocortisone—Anorexia—Methotrexate—testicular cancer	9.93e-05	0.000509	CcSEcCtD
Hydrocortisone—Syncope—Doxorubicin—testicular cancer	9.91e-05	0.000508	CcSEcCtD
Hydrocortisone—Oedema—Epirubicin—testicular cancer	9.75e-05	0.000499	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Epirubicin—testicular cancer	9.75e-05	0.000499	CcSEcCtD
Hydrocortisone—Hypotension—Methotrexate—testicular cancer	9.74e-05	0.000499	CcSEcCtD
Hydrocortisone—Loss of consciousness—Doxorubicin—testicular cancer	9.72e-05	0.000498	CcSEcCtD
Hydrocortisone—Infection—Epirubicin—testicular cancer	9.69e-05	0.000496	CcSEcCtD
Hydrocortisone—Shock—Epirubicin—testicular cancer	9.59e-05	0.000491	CcSEcCtD
Hydrocortisone—Convulsion—Doxorubicin—testicular cancer	9.58e-05	0.000491	CcSEcCtD
Hydrocortisone—Nervous system disorder—Epirubicin—testicular cancer	9.56e-05	0.00049	CcSEcCtD
Hydrocortisone—Hypertension—Doxorubicin—testicular cancer	9.54e-05	0.000489	CcSEcCtD
Hydrocortisone—Tachycardia—Epirubicin—testicular cancer	9.52e-05	0.000487	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Methotrexate—testicular cancer	9.49e-05	0.000486	CcSEcCtD
Hydrocortisone—Skin disorder—Epirubicin—testicular cancer	9.47e-05	0.000485	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Epirubicin—testicular cancer	9.43e-05	0.000483	CcSEcCtD
Hydrocortisone—Insomnia—Methotrexate—testicular cancer	9.42e-05	0.000483	CcSEcCtD
Hydrocortisone—Myalgia—Doxorubicin—testicular cancer	9.41e-05	0.000482	CcSEcCtD
Hydrocortisone—Anxiety—Doxorubicin—testicular cancer	9.38e-05	0.00048	CcSEcCtD
Hydrocortisone—Paraesthesia—Methotrexate—testicular cancer	9.36e-05	0.000479	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	9.35e-05	0.000479	CcSEcCtD
Hydrocortisone—Discomfort—Doxorubicin—testicular cancer	9.3e-05	0.000476	CcSEcCtD
Hydrocortisone—Anorexia—Epirubicin—testicular cancer	9.29e-05	0.000476	CcSEcCtD
Hydrocortisone—Dyspepsia—Methotrexate—testicular cancer	9.17e-05	0.00047	CcSEcCtD
Hydrocortisone—Hypotension—Epirubicin—testicular cancer	9.11e-05	0.000467	CcSEcCtD
Hydrocortisone—Decreased appetite—Methotrexate—testicular cancer	9.06e-05	0.000464	CcSEcCtD
Hydrocortisone—Oedema—Doxorubicin—testicular cancer	9.02e-05	0.000462	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Doxorubicin—testicular cancer	9.02e-05	0.000462	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Methotrexate—testicular cancer	8.99e-05	0.000461	CcSEcCtD
Hydrocortisone—Fatigue—Methotrexate—testicular cancer	8.98e-05	0.00046	CcSEcCtD
Hydrocortisone—Infection—Doxorubicin—testicular cancer	8.96e-05	0.000459	CcSEcCtD
Hydrocortisone—Pain—Methotrexate—testicular cancer	8.91e-05	0.000456	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Epirubicin—testicular cancer	8.88e-05	0.000455	CcSEcCtD
Hydrocortisone—Shock—Doxorubicin—testicular cancer	8.88e-05	0.000455	CcSEcCtD
Hydrocortisone—Nervous system disorder—Doxorubicin—testicular cancer	8.85e-05	0.000453	CcSEcCtD
Hydrocortisone—Insomnia—Epirubicin—testicular cancer	8.82e-05	0.000452	CcSEcCtD
Hydrocortisone—Tachycardia—Doxorubicin—testicular cancer	8.8e-05	0.000451	CcSEcCtD
Hydrocortisone—Skin disorder—Doxorubicin—testicular cancer	8.76e-05	0.000449	CcSEcCtD
Hydrocortisone—Paraesthesia—Epirubicin—testicular cancer	8.75e-05	0.000448	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Doxorubicin—testicular cancer	8.72e-05	0.000447	CcSEcCtD
Hydrocortisone—Anorexia—Doxorubicin—testicular cancer	8.6e-05	0.00044	CcSEcCtD
Hydrocortisone—Feeling abnormal—Methotrexate—testicular cancer	8.59e-05	0.00044	CcSEcCtD
Hydrocortisone—Dyspepsia—Epirubicin—testicular cancer	8.58e-05	0.00044	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Methotrexate—testicular cancer	8.52e-05	0.000436	CcSEcCtD
Hydrocortisone—Decreased appetite—Epirubicin—testicular cancer	8.48e-05	0.000434	CcSEcCtD
Hydrocortisone—Hypotension—Doxorubicin—testicular cancer	8.43e-05	0.000432	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Epirubicin—testicular cancer	8.42e-05	0.000431	CcSEcCtD
Hydrocortisone—Fatigue—Epirubicin—testicular cancer	8.41e-05	0.000431	CcSEcCtD
Hydrocortisone—Pain—Epirubicin—testicular cancer	8.34e-05	0.000427	CcSEcCtD
Hydrocortisone—Urticaria—Methotrexate—testicular cancer	8.28e-05	0.000424	CcSEcCtD
Hydrocortisone—Abdominal pain—Methotrexate—testicular cancer	8.24e-05	0.000422	CcSEcCtD
Hydrocortisone—Body temperature increased—Methotrexate—testicular cancer	8.24e-05	0.000422	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	8.22e-05	0.000421	CcSEcCtD
Hydrocortisone—Insomnia—Doxorubicin—testicular cancer	8.16e-05	0.000418	CcSEcCtD
Hydrocortisone—Paraesthesia—Doxorubicin—testicular cancer	8.1e-05	0.000415	CcSEcCtD
Hydrocortisone—Feeling abnormal—Epirubicin—testicular cancer	8.03e-05	0.000411	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Epirubicin—testicular cancer	7.97e-05	0.000408	CcSEcCtD
Hydrocortisone—Dyspepsia—Doxorubicin—testicular cancer	7.94e-05	0.000407	CcSEcCtD
Hydrocortisone—Decreased appetite—Doxorubicin—testicular cancer	7.84e-05	0.000402	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Doxorubicin—testicular cancer	7.79e-05	0.000399	CcSEcCtD
Hydrocortisone—Fatigue—Doxorubicin—testicular cancer	7.78e-05	0.000398	CcSEcCtD
Hydrocortisone—Urticaria—Epirubicin—testicular cancer	7.75e-05	0.000397	CcSEcCtD
Hydrocortisone—Pain—Doxorubicin—testicular cancer	7.71e-05	0.000395	CcSEcCtD
Hydrocortisone—Abdominal pain—Epirubicin—testicular cancer	7.71e-05	0.000395	CcSEcCtD
Hydrocortisone—Body temperature increased—Epirubicin—testicular cancer	7.71e-05	0.000395	CcSEcCtD
Hydrocortisone—Hypersensitivity—Methotrexate—testicular cancer	7.68e-05	0.000393	CcSEcCtD
Hydrocortisone—Asthenia—Methotrexate—testicular cancer	7.47e-05	0.000383	CcSEcCtD
Hydrocortisone—Feeling abnormal—Doxorubicin—testicular cancer	7.43e-05	0.000381	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Doxorubicin—testicular cancer	7.38e-05	0.000378	CcSEcCtD
Hydrocortisone—Pruritus—Methotrexate—testicular cancer	7.37e-05	0.000378	CcSEcCtD
Hydrocortisone—Hypersensitivity—Epirubicin—testicular cancer	7.18e-05	0.000368	CcSEcCtD
Hydrocortisone—Urticaria—Doxorubicin—testicular cancer	7.17e-05	0.000367	CcSEcCtD
Hydrocortisone—Body temperature increased—Doxorubicin—testicular cancer	7.13e-05	0.000365	CcSEcCtD
Hydrocortisone—Abdominal pain—Doxorubicin—testicular cancer	7.13e-05	0.000365	CcSEcCtD
Hydrocortisone—Diarrhoea—Methotrexate—testicular cancer	7.13e-05	0.000365	CcSEcCtD
Hydrocortisone—Asthenia—Epirubicin—testicular cancer	7e-05	0.000358	CcSEcCtD
Hydrocortisone—Pruritus—Epirubicin—testicular cancer	6.9e-05	0.000353	CcSEcCtD
Hydrocortisone—Dizziness—Methotrexate—testicular cancer	6.89e-05	0.000353	CcSEcCtD
Hydrocortisone—Diarrhoea—Epirubicin—testicular cancer	6.67e-05	0.000342	CcSEcCtD
Hydrocortisone—Hypersensitivity—Doxorubicin—testicular cancer	6.65e-05	0.00034	CcSEcCtD
Hydrocortisone—Vomiting—Methotrexate—testicular cancer	6.62e-05	0.000339	CcSEcCtD
Hydrocortisone—Rash—Methotrexate—testicular cancer	6.57e-05	0.000336	CcSEcCtD
Hydrocortisone—Dermatitis—Methotrexate—testicular cancer	6.56e-05	0.000336	CcSEcCtD
Hydrocortisone—Headache—Methotrexate—testicular cancer	6.53e-05	0.000334	CcSEcCtD
Hydrocortisone—Asthenia—Doxorubicin—testicular cancer	6.47e-05	0.000332	CcSEcCtD
Hydrocortisone—Dizziness—Epirubicin—testicular cancer	6.45e-05	0.00033	CcSEcCtD
Hydrocortisone—Pruritus—Doxorubicin—testicular cancer	6.38e-05	0.000327	CcSEcCtD
Hydrocortisone—Vomiting—Epirubicin—testicular cancer	6.2e-05	0.000317	CcSEcCtD
Hydrocortisone—Nausea—Methotrexate—testicular cancer	6.19e-05	0.000317	CcSEcCtD
Hydrocortisone—Diarrhoea—Doxorubicin—testicular cancer	6.17e-05	0.000316	CcSEcCtD
Hydrocortisone—Rash—Epirubicin—testicular cancer	6.15e-05	0.000315	CcSEcCtD
Hydrocortisone—Dermatitis—Epirubicin—testicular cancer	6.14e-05	0.000315	CcSEcCtD
Hydrocortisone—Headache—Epirubicin—testicular cancer	6.11e-05	0.000313	CcSEcCtD
Hydrocortisone—Dizziness—Doxorubicin—testicular cancer	5.97e-05	0.000306	CcSEcCtD
Hydrocortisone—Nausea—Epirubicin—testicular cancer	5.79e-05	0.000297	CcSEcCtD
Hydrocortisone—Vomiting—Doxorubicin—testicular cancer	5.74e-05	0.000294	CcSEcCtD
Hydrocortisone—Rash—Doxorubicin—testicular cancer	5.69e-05	0.000291	CcSEcCtD
Hydrocortisone—Dermatitis—Doxorubicin—testicular cancer	5.68e-05	0.000291	CcSEcCtD
Hydrocortisone—Headache—Doxorubicin—testicular cancer	5.65e-05	0.000289	CcSEcCtD
Hydrocortisone—Nausea—Doxorubicin—testicular cancer	5.36e-05	0.000274	CcSEcCtD
